Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Age-specific prevalence, transmission and phylogeny of TT virus in the Czech Republic

Saláková M., Němeček V., König J., Tachezy R.

. 2005 ; 4 (1) : 56.

Jazyk angličtina Země Velká Británie

Perzistentní odkaz   https://www.medvik.cz/link/bmc07507185

BACKGROUND: TT virus is prevalent worldwide, but its prevalence and genotype distribution in Central and East-Europe has not been determined. The high prevalence of TTV in multiply-transfused patients points to the importance of a parenteral mode of transmission, but since more than half of the general population is infected other possible routes of transmission must be considered. METHODS: In our study, we investigated the epidemiology, transmission and phylogeny of TTV in the Czech Republic. The following groups were selected: a control group of 196 blood donors, 20 patients with hemophilia, 49 intravenous drug users, 100 sex workers, 50 penitentiary prisoners, 208 healthy children aged 1 to 14 years, 54 cord blood samples, 52 patients with non-A-E hepatitis, 74 patients with hepatitis C, and 51 blood donors with increased ALT levels. Primers specific for the non-coding region were used. The genotype distribution was studied in 70 TTV-positive samples. RESULTS: The prevalence rate of TTV among the Czech population was 52.6%. We have shown that TTV is not transmitted prenatally. Children were infected after birth with two peaks: one at the age of two years and the other after the beginning of primary school. Adults have shown a further increase in the TTV prevalence with age. The highest TTV prevalence was found in the group of patients who had received multiple blood transfusions. The TTV prevalence rate in subjects at an increased risk of sexual transmission was not significantly higher than in the general population. Genotypes G2 and G1 were most prevalent among the Czech population, followed by G8 and G3. The subjects positive for markers of HBV and/or HCV infection tested significantly more often TTV DNA positive, which is suggestive of a common route of transmission of these three infections. CONCLUSIONS: This study on TTV prevalence, mode of transmission and age-specific prevalence is the most extensive study performed in Central and Eastern Europe. It showed insights into the epidemiology of TTV infection, but failed to associate TTV infection with clinical manifestations.

000      
04870naa 2200625 a 4500
001      
bmc07507185
003      
CZ-PrNML
005      
20130218182343.0
008      
080731s2005 xxk e eng||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Saláková, Martina $7 xx0086174
245    10
$a Age-specific prevalence, transmission and phylogeny of TT virus in the Czech Republic / $c Saláková M., Němeček V., König J., Tachezy R.
314    __
$a Department of Experimental Virology, Institute of Hematology and Blood Transfusion, U Nemocnice 1, 128 20 Prague 2, Czech Republic. martina.salakova@uhkt.cz
520    9_
$a BACKGROUND: TT virus is prevalent worldwide, but its prevalence and genotype distribution in Central and East-Europe has not been determined. The high prevalence of TTV in multiply-transfused patients points to the importance of a parenteral mode of transmission, but since more than half of the general population is infected other possible routes of transmission must be considered. METHODS: In our study, we investigated the epidemiology, transmission and phylogeny of TTV in the Czech Republic. The following groups were selected: a control group of 196 blood donors, 20 patients with hemophilia, 49 intravenous drug users, 100 sex workers, 50 penitentiary prisoners, 208 healthy children aged 1 to 14 years, 54 cord blood samples, 52 patients with non-A-E hepatitis, 74 patients with hepatitis C, and 51 blood donors with increased ALT levels. Primers specific for the non-coding region were used. The genotype distribution was studied in 70 TTV-positive samples. RESULTS: The prevalence rate of TTV among the Czech population was 52.6%. We have shown that TTV is not transmitted prenatally. Children were infected after birth with two peaks: one at the age of two years and the other after the beginning of primary school. Adults have shown a further increase in the TTV prevalence with age. The highest TTV prevalence was found in the group of patients who had received multiple blood transfusions. The TTV prevalence rate in subjects at an increased risk of sexual transmission was not significantly higher than in the general population. Genotypes G2 and G1 were most prevalent among the Czech population, followed by G8 and G3. The subjects positive for markers of HBV and/or HCV infection tested significantly more often TTV DNA positive, which is suggestive of a common route of transmission of these three infections. CONCLUSIONS: This study on TTV prevalence, mode of transmission and age-specific prevalence is the most extensive study performed in Central and Eastern Europe. It showed insights into the epidemiology of TTV infection, but failed to associate TTV infection with clinical manifestations.
650    _2
$a infekce DNA virem $x epidemiologie $x přenos $x virologie $7 D004266
650    _2
$a sexuálně přenosné nemoci virové $x epidemiologie $x přenos $x virologie $7 D015229
650    _2
$a Torque teno virus $x genetika $x klasifikace $7 D022783
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    _2
$a věkové rozložení $7 D017677
650    _2
$a senioři $7 D000368
650    _2
$a dárci krve $x statistika a číselné údaje $7 D001782
650    _2
$a studie případů a kontrol $7 D016022
650    _2
$a dítě $7 D002648
650    _2
$a předškolní dítě $7 D002675
650    _2
$a DNA virů $x izolace a purifikace $x krev $7 D004279
650    _2
$a genotyp $7 D005838
650    _2
$a hemofilie A $x komplikace $7 D006467
650    _2
$a kojenec $7 D007223
650    _2
$a lidé středního věku $7 D008875
650    _2
$a fylogeneze $7 D010802
650    _2
$a polymerázová řetězová reakce $7 D016133
650    _2
$a prevalence $7 D015995
650    _2
$a vězni $x statistika a číselné údaje $7 D011329
650    _2
$a intravenózní abúzus drog $x komplikace $7 D015819
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a financování organizované $7 D005381
651    _2
$a Česká republika $x epidemiologie $7 D018153
700    1_
$a Němeček, Vratislav, $7 xx0060525 $d 1950-
700    1_
$a König, Jaroslav $7 xx0061433
700    1_
$a Tachezy, Ruth $7 xx0060363
773    0_
$w MED00008185 $t BMC infectious diseases $g Roč. 4, č. 1 (2005), s. 56 $x 1471-2334
910    __
$a ABA008 $b x $y 9
990    __
$a 20080721085927 $b ABA008
991    __
$a 20130218182542 $b ABA008
999    __
$a ok $b bmc $g 622792 $s 475225
BAS    __
$a 3
BMC    __
$a 2005 $b 4 $c 1 $d 56 $i 1471-2334 $m BMC infectious diseases $x MED00008185
LZP    __
$a 2008-Doreen

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...